Disrupted gut microecology after high-dose 131I therapy and radioprotective effects of arachidonic acid supplementation
European Journal of Nuclear Medicine and Molecular Imaging · 2024
DOI: 10.1007/s00259-024-06688-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2024. Verfasst von Ganghua Lu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Nuclear Medicine Center, Imaging Clinical Medical Center, Institute of Nuclear Medicine, Department of Nuclear Medicine, Shanghai Tenth Peop…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Iodine Radioisotopes, Radiation-Protective Agents, Arachidonic Acid. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shanghai, National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Background
Despite the potential radiotoxicity in differentiated thyroid cancer (DTC) patients with high-dose 131 I therapy, the alterations and regulatory mechanisms dependent on intestinal microecology remain poorly understood. We aimed to identify the characteristics of the gut microbiota and metabolites in DTC patients suffering from high-dose 131 I therapy and explore the radioprotective mechanisms underlying arachidonic acid (ARA) treatment.
Methods
A total of 102 patients with DTC were recruited, with fecal samples collected before and after 131 I therapy for microbiome and untargeted and targeted metabolomic analyses. Mice were exposed to total body irradiation with ARA replenishment and antibiotic pretreatment and were subjected to metagenomic, metabolomic, and proteomic analyses.
Results
131 I therapy significantly changed the structure of gut microbiota and metabolite composition in patients with DTC. Lachnospiraceae were the most dominant bacteria after 131 I treatment, and metabolites with decreased levels and pathways related to ARA and linoleic acid were observed. In an irradiation mouse model, ARA supplementation not only improved quality of life and recovered hematopoietic and gastrointestinal systems but also ameliorated oxidative stress and inflammation and preserved enteric microecology composition. Additionally, antibiotic intervention eliminated the radioprotective effects of ARA. Proteomic analysis and ursolic acid pretreatment showed that ARA therapy greatly influenced intestinal lipid metabolism in mice subjected to irradiation by upregulating the expression of hydroxy-3-methylglutaryl-coenzyme A synthase 1.
Conclusion
These findings highlight that ARA, as a key metabolite, substantially contributes to radioprotection. Our study provides novel insights into the pivotal role that the microbiota-metabolite axis plays in radionuclide protection and offers effective biological targets for treating radiation-induced adverse effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Nuclear Medicine Center, Imaging Clinical Medical Center, Institute of Nuclear Medicine, Department of Nuclear Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, 200072…
- Department of Nuclear Medicine, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510289, China. lidan269@mail.sysu.edu.cn.
ORCID-Profile: Zhongwei Lv
Förderung
- Natural Science Foundation of Shanghai
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
- Shanghai Leading Talent Program sponsored by Shanghai Human Resources and Social Security Bureau
- Shanghai Municipal Health Commission
Zitieren
APA
Lu, G., Gao, D., Jiang, W., Yu, X., Tong, J., Liu, X., Qiao, T., Wang, R., Zhang, M., Wang, S., Yang, J., Li, D., & Lv, Z. (2024). Disrupted gut microecology after high-dose 131I therapy and radioprotective effects of arachidonic acid supplementation. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-024-06688-9
Vancouver
Lu G, Gao D, Jiang W, Yu X, Tong J, Liu X, et al. Disrupted gut microecology after high-dose 131I therapy and radioprotective effects of arachidonic acid supplementation. European Journal of Nuclear Medicine and Molecular Imaging. 2024. doi:10.1007/s00259-024-06688-9
BibTeX
@article{Lu2024,
author = {Lu, Ganghua and Gao, Dingwei and Jiang, Wen and Yu, Xiaqing and Tong, Junyu and Liu, Xiaoyan and Qiao, Tingting and Wang, Ru and Zhang, Mengyu and Wang, Shaoping and Yang, Jianshe and Li, Dan and Lv, Zhongwei},
title = {Disrupted gut microecology after high-dose 131I therapy and radioprotective effects of arachidonic acid supplementation},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2024},
doi = {10.1007/s00259-024-06688-9}
}
EUVIMED